About 25% of Doctors Screen Men for Prostate Cancer without Asking them – Study
Prostate Specific Antigen (PSA) Test is a basic test to discover whether a man has prostate cancer or not. Although it is not to be absolutely relied upon, it is still a first step marker for prostate cancer.
A new study has reported that one in four family doctors do not seek the patient’s approval before screening them for prostate cancer.
This attitude may somehow undermine the importance of the patient having to learn of the PSA screening and making vital decisions for treatment.
The study was conducted by researchers from the John’s Hopkins Medicine in Baltimore, Maryland. From an article initially written by Genevra Pittman and published in Reuters and posted in Yahoo Health January 14, 2013, the following details were highlighted:
One in four family doctors doesn’t ask male patients before screening them for prostate cancer, according to a new survey.
So-called prostate specific antigen (PSA) testing has been controversial in recent years because of uncertainty about whether it actually saves lives and concern about side effects from potentially unnecessary and invasive follow-up tests and treatments.
The U.S. Preventive Services Task Force, a government-backed panel, recommended against PSA tests for normal-risk men in 2012, saying there is no evidence that screening has more benefits than harms.
Screening is still acceptable, according to the USPSTF, if the man being tested understands the possible outcomes – good and bad – and makes the personal decision to get tested.
But that may not always happen, researchers found.
“There’s some amount of confusion for providers about what the right course of action is,” said Dr. Craig Pollack, who has studied doctors’ attitudes toward prostate cancer screening at Johns Hopkins Medicine in Baltimore, Maryland.
In addition, “one of the big drivers of PSA screening is patient expectations – that doctors think their patients expect to get screening,” said Pollack, who was not involved in the new research.
For the current study, Robert Volk from The University of Texas MD Anderson Cancer Center in Houston and his colleagues surveyed 246 family doctors in 2007 and 2008 about whether and how they screened their male patients for prostate cancer.
Of those doctors, 24 percent said they ordered PSA tests without first discussing screening with patients.
Another 48 percent talked about the possible benefits and harms with their patients and let men decide for themselves whether to get screened.
Most of the remaining doctors also discussed screening’s pluses and minuses but specifically recommended it, Volk’s team reported Monday in the Annals of Family Medicine.
It’s concerning that some men may not know all the implications of being screened but get PSA tests anyway, researchers said.
“One of the main concerns with PSA screening is it can set people down a pathway of getting the biopsy, potentially getting a cancer diagnosis and treatment that may not have (been) needed,” Pollack told Reuters Health.
Volk agreed, calling prostate cancer screening the beginning of a “slippery slope.” That’s because some men will be diagnosed with slow-growing cancer and will need to decide whether to get treatment – and risk side effects such as impotence and incontinence – or wait to see if the cancer grows and poses any danger.
“Men really need to be aware of these issues (when they are) making a decision about screening, because of all the decisions that come after that,” he told Reuters Health.
About one in six men will be diagnosed with prostate cancer during his lifetime, according to the American Cancer Society. However far fewer – about one in 36 – will die of the disease, in part because prostate cancer is often slow-growing and affects mostly older men.
“A fairly large proportion of men will die with their prostate cancer instead of from their prostate cancer,” Pollack explained.
Volk said men “need to be given quality information” about the benefits and risks of PSA tests, including what could happen after a positive test.
Men, he added, “should feel empowered to ask their doctors about screening and have a very frank discussion about what’s important to them.” Source.
Conclusively, the above details reemphasized the need importance of men having to get quality information and make the right decisions about prostate cancer.
It is important that doctors ask patients about the screening before going ahead with it.
Although the screening is important, the man has the right to contribute to the final decisions that may affect his treatment.
More so, men should not fail to ask doctors about the implications of all diagnoses and treatment of their prostate conditions.
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:
(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)
- Prostate Cancer Test- Doctors Against The New Guidelines On PSA Screening
- Prostate Cancer Screening For Middle-Age Men Recommended By a New Study
- Doctors Differ On Whether To Stop PSA Screening
- Study Shows PSA Testing Improves Life Span for Prostate Cancer Men, as the American Cancer Society Slams the Findings
- Surgery Does Not Reduce All-Cause Mortality among Men with Localized Prostate Cancer – Study
- Doctors Clears The Air On Six Myths Of Prostate Cancer
- Fizzy Drinks Increase Risk of Aggressive Prostate Cancer in Men – Study
- Study Shows Aspirin Intake in Men with Prostate Cancer Helped to Reduce Their Mortality
- Radiation Treatment after Prostatectomy Improves Prostate Cancer Results for Men – Study
- Prostate Cancer Tumor Worse in Overweight Men – New Study
- Study Suggests Androgen Deprivation May Do More Harm than Good in Men with Prostate Cancer
- Metabolic Syndrome Increases the Risks of Death in Men with Prostate Cancer – Study
- Doctors in Australia to Use Computer Science to Improve Prostate Cancer Treatment
- Targeted Prostate Cancer Screening Can Save Men from Unnecessary Cost and Treatment
- Top US Prostate Cancer Specialist Challenges Use of Surgical Options by Doctors